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Summary 
Racial differences in erythrocyte potassium effluxes mediated 
by two loop-diuretic sensitive modes of cotransport were 
compared. In red cells loaded to contain approximately equimolar 
amounts of sodium and potassium, black subjects had lower 
bumetanide-sensitive sodium-dependent net potassium effluxes as 
compared to whites. In fresh, washed erythrocytes pretreated with 
N-ethylmaleimide (NEM), maximal net potassium efflux was greater in 
blacks than in whites. NEM-stimulated potassium efflux was 
partially inhibited by bumetanide but only at very high 
concentrations. The quantitative differences in these two modes of 
potassium efflux suggest that NEM-stimulated potassium efflux is 
not an altered mode of sodium-dependent potassium efflux. 
We (i) and others (2-6) have noted a striking racial difference in the 
maximal rates of furosemide-sensitive effluxes of sodium and potassium from 
sodium-loaded erythrocytes. In addition to a race-related alteration in the 
activity of furosemide-sensitive transport, deviations from the expected 1Na:l 
K stoichiometry of classical sodium-potassium cotransport have been noted in 
blacks (1,5,6). The description in sheep (7,8) and human (9-11) erythrocytes 
of a ouabain-insensitive potassium efflux pathway, stimulated by the sulfhydryl 
reagent N-ethylmaleimide (NEM), partially sensitive to furosemide and capable 
of mediating net potassium efflux in the absence of sodium efflux, suggested a 
possible explanation for the racial differences in furosemide-sensitlve 
fluxes. We therefore measured maximal net ouabain-insensitive sodium and 
potassium effluxes in red cells loaded with equimolar amounts of the two ions 
and also in fresh cells treated with NEM. We demonstrated that while 
bumetanide-inhibited sodium and potassium transport is depressed in blacks, 
NEM-stimulated potassium efflux is greater, suggesting a dissociation between 
these two systems. It is possible that the NEM-stimulated pathway contributes 
to previously observed racial differences in furosemide-sensitive cation 
fluxes. 
Methods 
Eleven white and an equal number of black normal volunteers, with no known 
cardiovascular, renal or endocrine disorders, were recruited by public adver- 
tisement. Race was.self-determined, and no attempt was made to control for 
other ethnic derivation. Erythrocyte cation and water composition were meas- 
ured in fresh washed cells. Maximal ouabain-insensitive sodium and potassium 
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effluxes were determined in cells loaded by a nystatin technique with equimolar 
amounts of sodium and potassium as previously described (I), with the exception 
that 0.I mM bumetanide (Bumex®, Hoffman-LaRoche, Nutley, N.J.) was substituted 
for 1 mM furosemide when required. For determination of NEM-stlmulated 
effluxes, red cells were washed three times with an ice-cold washing solution 
consisting of (mM) 75 MgCI2, 85 sucrose, i0 TRIS-MOPS (pH 7.4 at 4 ° C), then 
suspended at an approximate hematocrit of 10% in a solution (MS) of (mM) 75 
MgCI2, 85 sucrose, I0 glucose, 0.I ouabain, i0 TRIS-MOPS (pH 7.4 at 37 ° C) and 
transferred to a shaking water bath at 37 ° C. At zero time, NEM (Sigma 
Chemical Co., St. Louis, MO), freshly prepared as a I M stock in DMSO, was 
added to a final concentration of 1 mM. The cells were incubated in the 
presence of NEM for 15 minutes and were then removed and washed three times in 
MS. Allquots of the washed cells were taken for determination of cell elec- 
trolytes and water, and packed cell hematocrit was determined in duplicate. 
The remaining cells were suspended at a hematocrit of 2-4% in MS, mixed and 
aliquoted into six tubes. These tubes were incubated in a shaking water bath 
at 37 ° C and duplicates were removed at I0, 20 and 30 minutes, iced for one 
minute and centrifuged at 2000 g for five minutes. The supernatants were 
removed and analyzed by atomic absorption spectrophotometry (Perkin-Elmer 2380 
AA spectrophotometer, Perkin-Elmer Corporation, Norwalk, Connecticut) for 
sodium and potassium concentrations. Efflux rates were determined by linear 
regression fits of the external cation concentrations. Regression coefficients 
(r) of ~ 0.98 were considered technically satisfactory. In the experiment to 
determine the response of NEM-stimulated potassium efflux to bumetanide, the 
drug was prepared as a 3 M solution in DMSO and an appropriate volume of DMSO 
was added to the control tube. Data were analyzed by t-test with pairing when 
appropriate and p values of ~0.05 were considered significant. 
Results 
Erythrocyte cation and water contents: Black subjects had a significantly 
higher cell sodium content in fresh, washed cells when compared to whites. 
Cell potassium was lower and cell water was slightly higher in blacks, but 
neither difference was significant. 
TABLE I 
Erythrocyte Electrolyte and Water Contents in Fresh, Washed Cells 
(mean ± SD, n = Ii for both groups) 
Whites Blacks 
Sodium 8.07 ± 0.87 9.39 ± 1.50" 
Potassium 97.77 ± 4.38 93.07 ± 4.74 
Water 64.72 ± 1.30 65.95 ± 2.14 
* p<0.05 
Bumetanlde-sensitive effluxes from nystatin-treated, sodium-loaded 
cells: Bumetanide-sensitive sodium and potassium effluxes were s~n~flcantly 
in blacks than in whites, as were the rate coefficients ( k' ) for 
each ion. Ouabain-insensitive, bumetanide-insensiti~e ,leffluxe~e~re not 
k l~ , ~ . different, nor were the respective rate coefficients ( Binsens )" 
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TABLE II 
Effect of Bumetanide on Ouabain-lnsensitive Sodium and Potassium Effluxes 
And Rate Coefficients (k) From Nystatln-Treated Erythrocytes 
(mean ± SD, n = ll for both groups) 
Whites Blacks 
Initial Cell Contents: 
Sodium (mmoles/1 cells) 





± 5.66 60.38 ± 3.11" 
± 2.31 52.98 ± 5.03 
± 1.75 66.09 ± 1.55 
Bumetanide-sensitive Effluxes: 
Sodium (mmol~s/1 cells • h) 0.568 ± 0.222 
~a -i 
kBSens. (h ) 0.0107 ± 0.0046 
Potassium (mmgles/l cells • h) 0.633 ± 0.148 
kBSens. (h -L) 0.0121 ± 0.0029 
Bumetanide-insensitive Effluxes: 
Sodium (mmoles~l cells • h) 1.433 ± 0.599 
Na -i 
kBlnsens. (h ) 0.0264 ± 0.0116 
Potassium (mmol~s/l cells • h) 1.053 ± 0.437 
k~insens. (h ~) 0.0201 ± 0.0082 
0.192 ± 0.173 ** 
0.0036 ± 0.0034** 
0.200 ± 0.159"* 
0.0038 ± 0.0033** 
1.302 ± 0.424 
0.0216 ± 0.0075 
1.046 ± 0.268 
0.0200 ± 0.0068 
* p<O.05, ** p<O.01, blacks versus whites. 
Effects of NEM treatment: Blacks showed greater net potassium efflux 
compared to whites after exposure of cells to i mM NEM for 15 minutes. No 
sodium efflux was detectable in NEM-treated cells in either racial group. 
Exposure of cells to NEM in the presence of chloride resulted in a similar 
significant decrease in the percentage of cell water in both racial groups 
(whites: -2.49 ± 1.59, p<O.Ol versus fresh, washed cells by paired t-test; 
blacks: -2.60 ± 1.39, p<0.01 versus fresh, washed cells by paired t-test). 
Such shrinkage can be prevented by the use of nitrate substitution for chloride 
(12). The slight increases in sodium and potassium content in washed cells 
following NEM treatment as compared to fresh cells (Table I) were not 
statistically significant. 
TABLE III 
Effect of NEM Treatment on Cell Contents, Net Potassium Efflux 
and Potassium Efflux Rate Coefficient (kKNEM) 
(mean ± SD, n = ii for both groups) 
Initial Cell Contents: 
Sodium (mmoles/l cells) 
Potassium (mmoles/l cells) 
Water (%) 
K efflux (mmoles/l cells) 
kKNE M (h -1 ) 
Whites Blacks 
8.01 ± 1.21 
98.58 ± 5.09 
62.24 ± 0.60 
8.22 ± 2.39 
0.0831 ± 0.0253 
9.69 ± 2.06* 
97.56 ± 7.65 
63.36 ± 1.37 
12.51 ± 2.83** 
0.1283 ± 0.0259** 
* p<0.05, ** p<0.01, blacks versus whltes 
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Bumetanide inhibited a substantial fraction of the ~M-stimulated potas- 
sium efflux, but very high concentrations were required. In the example shown, 
50% inhibition of the NEM-stimulated potassium efflux was achieved at approxi- 
mately 1.0 mM concentration of bumetanide, and complete inhibition was not 
obtained with the highest concentration tested, 3 mM, confirming the earlier 
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FIG. 1 
Bumetanide inhibition of potassium efflux from erythrocytes exposed 
to NEM. Dashed line represents level of potassium efflux in 
absence of bumetanide. Approximately 70% inhibition was achieved 
at the highest concentration of bumetanide tested, 3 mM. 
Discussion 
Similarities in the effect of NEM on sheep and human cells, including a 
chloride dependence (8,10-12) and loop diuretic sensitivity of the induced 
potassium flux (10,12), suggest a similar mode of action in both species. 
While the precise details of the molecular site of the NEM effect are unknown, 
the suggestion was initially forwarded by Lauf et al that NEM-stimulated 
potassium efflux might represent an "uncoupled" action of the Na:K:2CI 
cotransport system (9), although subsequent studies by the same authors have 
recently provided evidence suggesting that the potassium efflux unmasked by NEM 
is not an altered mode of Na:K:2 C1 cotransport (ii). We studied the effect of 
NEM in blacks and whites because racial differences in furosemide-sensitive 
effluxes attributed to the classical Na:K:2CI cotransport pathway have been 
well documented. The finding that NEM-stimulated sodium-independent potassium 
efflux is greater in blacks as compared to whites while, as expected, the 
maximal sodium-dependent bumetanide-sensitive potassium efflux is less, 
suggests that the two pathways are independent. We therefore favor the 
interpretation that NEM-stimulated potassium efflux represents a second loop- 
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diuretic sensitive pathway, perhaps related to K:CI cotransport as suggested by 
Wiater and Dunham (i0) and by Lauf et al (ii). The physiological role of such 
a pathway in cation movements in normal human erythrocytes is not yet known. 
Inhibition of NEM-stimulated potassium efflux by furosemide (10,12) and 
humetanide (ll) has been previously reported. This inhibition seems to be 
enhanced by the presence of external potassium or rubidium (and slightly by 
external sodium) (13). In the absence of external monovalent cations, the dose 
response curve to furosemide is shifted to the right By at least two orders of 
magnitude when compared to concentrations required for inhibition of the 
classical Na:K:2C1 cotransport system (9,11,13). We employed the loop diuretic 
bumetanide in this study because in our hands high concentrations of furosemide 
have occasionally resulted in hemolysis, especially in black subjects. Partial 
inhibition of NEM-induced potassium efflux was demonstrable at very high con- 
centrations of bumetanide as has been reported by Lauf et al (ll). Synergism 
between bumetanide and external cations has been noted in turkey red cells 
(15), and potassium may be important in modulating the inhibitory effect of 
bumetanide on NEM-stimulated potassium fluxes. Whether external ions alter the 
affinity of loop diuretics for the transport site involved in the NEM effect or 
modify the Vma x of potassium transport is unknown, but Lauf has suggested a 
complex interaction based on his work with furosemide in sheep red cells 
(13). Further characterization of the racial difference in NEM-stimulated 
potassium efflux should include studies of the effect of bumetanide and the 
influence of external cations. 
Racial differences, confirmed by this study, have previously been noted 
for red blood cell sodium content (16) and furosemide-sensitive sodium and 
potassium effluxes (I). The relationship of the present observation to these 
or other race-related membrane differences in sodium-lithium countertransport 
(1,4,5) and passive membrane permeability to lithium (I) is unknown, as this 
study represents the first report of an accelerated ouabain-insensitive potas- 
sium transport system in blacks. Additionally, the considerable 
interindividual variability for NEM-stimulated potassium efflux within each 
race suggests the need for studies of other factors determininig the activity 
of this system. Further work should clarify the role of the NEM-stlmulated 
pathway in physiologic potassium movements in red blood cells and possibly in 
other tissues. 
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